Smiths Industries Medical Systems (SIMS) goes from strength to strength
This article was originally published in Clinica
Executive Summary
A strong performance by Smiths Industries Medical Systems in the year ended August 5th, 1995, contributed to a 23% increase in corporate operating profits of £140.9 million ($211.4 million) on turnover up 17% to £899.3 million. Medical Systems contributed 45% of total operating profits, rising 34% to £63 million in the year. Turnover by the division rose 37% to £275.4 million.
You may also be interested in...
Small Sterilization Companies Poised To Meet EtO Emissions Goals On Time
Small sterilizers told Medtech Insight that they were ready for the EPA’s controversial EtO emissions rule, while community advocates expressed concerns.
Day One Springs Into Commercial Action With Ojemda Approval
The company is targeting around 200 centers that treat the vast majority of the few thousand pediatric low-grade glioma patients who are candidates for the RAF-targeting drug.
At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use
At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.